Neuca

A consortium of China-based pharmaceutical companies, potentially including the state-owned giant Sinopharm (HKG: 1099), is reportedly considering the acquisition of Poland-based drug wholesaler Neuca. According to sources, the potential sale was discussed during a recent consultation between Neuca and Poland’s Competition and Consumer Office UOKIK. However, no specifics regarding the…